All In Biotech

Free tool

Drugs in development

Investigational drugs and biologics in industry-sponsored Phase 2 and Phase 3 trials that are active or finished in the last two years, and that FDA has not approved. Built from 10,322 ClinicalTrials.gov records, with code names and generic names merged. For approved drugs, use Drug Search.

Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations

Drugs in development

3,685

Not FDA-approved

In Phase 3

1,424

Highest phase reached

Matching your filters

278

Reset

278 drugs in development

Names, sponsors and conditions come from the trial records. Click a drug for its trials.

  • DB-3QPhase 22 trials

    Direct Biologics, LLC · Perianal Fistula Due to Crohn's Disease, Crohn Disease (CD)

  • DISC-0974Phase 22 trials

    Disc Medicine, Inc · Anemia, Inflammatory Bowel Disease (IBD), Inflammatory Bowel Disease (IBD); Anemia

  • EltrekibartLY3041658Phase 22 trials

    Eli Lilly · Ulcerative Colitis, Ulcerative Colitis Chronic, Hidradenitis Suppurativa

  • FB825Phase 22 trials

    Oneness Biotech Co., Ltd. · Allergic Asthma, Atopic Dermatitis

  • GR2301Phase 22 trials

    Genrix (Shanghai) Biopharmaceutical Co., Ltd. · Vitiligo

  • HB0043Phase 22 trials

    Shanghai Huaota Biopharmaceutical Co., Ltd. · Acne Vulgaris, Hidradenitis Suppurativa

  • HSK39297 300mgQDPhase 22 trials

    Haisco Pharmaceutical Group Co., Ltd. · IgA Nephropathy (IgAN), Lupus Nephritis (LN)

  • HSK47388Phase 22 trials

    Haisco Pharmaceutical Group Co., Ltd. · Plaque Psoriasis, Ulcerative Colitis (UC)

  • ICG318Phase 22 trials

    iCell Gene Therapeutics · Inflammatory Bowel Diseases (IBD), Systemic Lupus Erythematosus (SLE), Lupus Nephritis (LN)

  • JAB-8263Phase 22 trials

    Jacobio Pharmaceuticals Co., Ltd. · Rheumatoid Arthritis (RA), NSCLC, SCLC

  • JYP0061Experimental Drug GroupPhase 22 trials

    Guangzhou JOYO Pharma Co., Ltd · Moderate-to-severe Atopic Dermatitis, Neuromyelitis Optica Spectrum Disorders

  • LY4005130Phase 22 trials

    Eli Lilly · Alopecia Areata, Vitiligo, Non-Segmental Vitiligo (NSV)

  • LY4395089Phase 22 trials

    Eli Lilly · Crohn Disease, Colitis, Ulcerative

  • ModzatinibATI-2138Phase 22 trials

    Aclaris Therapeutics, Inc. · Lichen Planus, Atopic Dermatitis

  • NKX019Phase 22 trials

    Nkarta, Inc. · Lupus Nephritis, Primary Membranous Nephropathy, Systemic Sclerosis

  • ORKA-001Phase 22 trials

    Oruka Therapeutics, Inc. · Plaque Psoriasis

  • RosnilimabANB030Phase 22 trials

    AnaptysBio, Inc. · Rheumatoid Arthritis, Ulcerative Colitis

  • SHR0302BasePhase 22 trials

    Jiangsu HengRui Medicine Co., Ltd. · Vitiligo, Non-segmental Vitiligo

  • SL-325Phase 22 trials

    Shattuck Labs, Inc. · Crohn's Disease, Hidradenitis Suppurativa (HS)

  • SPY001SPY001-001Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

  • SPY002SPY002-091Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

  • SPY002-072SPY072Phase 22 trials

    Spyre Therapeutics, Inc. · Rheumatoid Arthritis, Psoriatic Arthritis, Axial Spondyloarthritis

  • SPY003SPY003-207Phase 22 trials

    Spyre Therapeutics, Inc. · Ulcerative Colitis, Inflammatory Bowel Diseases, Colitis

  • TibulizumabZB-106Phase 22 trials

    Zura Bio Inc · Hidradenitis Suppurativa (HS), Systemic Sclerosis (SSc), Scleroderma

  • TollB-001Phase 22 trials

    Toll Biotech Co. Ltd. (Beijing) · Rheumatoid Arthritis (RA), Systemic Sclerosis (SSc)

  • TQB3702Phase 22 trials

    Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · B-cell Lymphoma, Systemic Lupus Erythematosus

  • TrosunilimabABBV-382Phase 22 trials

    AbbVie · Crohn's Disease, Ulcerative Colitis

  • vilamakitugXB2001, NatrunixPhase 22 trials

    XBiotech, Inc. · Axial Spondyloarthritis, Ankylosing Spondylitis, r-axSpA

  • VIS954Phase 22 trials

    Otsuka · Antineutrophil Cytoplasmic Antibody-associated Vasculitis, Inflammatory Skin Diseases

  • XKH001InjectionXKH001Phase 22 trials

    Zhejiang Kanova Biopharmaceutical Co., LTD · COPD, Atopic Dermatitis

  • YK012Phase 22 trials

    Excyte Biopharma Ltd · Systemic Lupus Erythematosus (SLE), B-cell Acute Lymphoblastic Leukemia

  • ABBV-547Phase 21 trial

    AbbVie · Psoriatic Arthritis

  • ABBV-668Phase 21 trial

    AbbVie · Ulcerative Colitis

  • ABBV-8736Phase 21 trial

    AbbVie · Crohn's Disease

  • ACT-777991Phase 21 trial

    Idorsia Pharmaceuticals Ltd. · Non-Segmental Vitiligo

  • AD-3031Phase 21 trial

    Moogene Medi Co., Ltd · Androgenetic Alopecia

  • AD-303APhase 21 trial

    Moogene Medi Co., Ltd · Androgenetic Alopecia

  • ADX-097Phase 21 trial

    Akebia Therapeutics · IgA Nephropathy, Lupus Nephritis (LN), C3 (Complement Component 3) Glomerulopathy

  • ALD-102Phase 21 trial

    Aldena Therapeutics · Alopecia Areata (AA)

  • ALTB-268Phase 21 trial

    AltruBio Inc. · Ulcerative Colitis

  • ATH-063Phase 21 trial

    Athos Therapeutics Inc · Ulcerative Colitis, Inflammatory Bowel Diseases, Autoimmune Diseases

  • ATI-045Phase 21 trial

    Aclaris Therapeutics, Inc. · Atopic Dermatitis, Atopic, Dermatitis

  • AZD1163Phase 21 trial

    AstraZeneca · Rheumatoid Arthritis

  • BBT001Phase 21 trial

    Bambusa Therapeutics · Chronic Spontaneous Urticaria

  • BGP-014Phase 21 trial

    BioGaia Pharma AB · Ulcerative Colitis

  • BI 3000202Phase 21 trial

    Boehringer Ingelheim · Systemic Lupus Erythematosus

  • BI 3032950Phase 21 trial

    Boehringer Ingelheim · Ulcerative Colitis

  • BMS-986528Phase 21 trial

    Bristol Myers Squibb · Arthritis, Rheumatoid

  • BriquilimabJSP191Phase 21 trial

    Jasper Therapeutics, Inc. · Chronic Spontaneous Urticaria

  • COL-5671-PROPhase 21 trial

    Coultreon Biopharma · Plaque Psoriasis

NewerPage 4 of 6Older

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.